EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
Open Access
- 1 February 2014
- journal article
- practice guideline
- Published by Elsevier BV in Journal of Hepatology
- Vol. 60 (2), 392-420
- https://doi.org/10.1016/j.jhep.2013.11.003
Abstract
No abstract availableKeywords
This publication has 227 references indexed in Scilit:
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statementJournal of Hepatology, 2012
- 1419 A RANDOMIZED TRIAL COMPARING RIBAVIRIN DOSE REDUCTION VERSUS ERYTHROPOIETIN FOR ANEMIA MANAGEMENT IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC HEPATITIS C RECEIVING BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRINJournal of Hepatology, 2012
- Review and management of drug interactions with boceprevir and telaprevirHepatology, 2012
- Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionHepatology, 2011
- Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-α2a and RibavirinClinical Gastroenterology and Hepatology, 2011
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug usersJournal of Hepatology, 2010
- Increased caffeine consumption is associated with reduced hepatic fibrosisHepatology, 2009
- Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug usersEuropean Journal of Epidemiology, 2007